137 related articles for article (PubMed ID: 33224467)
1. Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research.
Cohen D; Recalt A
Ther Adv Psychopharmacol; 2020; 10():2045125320964097. PubMed ID: 33224467
[TBL] [Abstract][Full Text] [Related]
2. Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review.
Cohen D; Recalt A
Psychother Psychosom; 2019; 88(2):96-104. PubMed ID: 30923288
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.
Récalt AM; Cohen D
Psychother Psychosom; 2019; 88(2):105-113. PubMed ID: 30893683
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
5. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
6. How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.
Hengartner MP
Ther Adv Psychopharmacol; 2020; 10():2045125320921694. PubMed ID: 32435449
[TBL] [Abstract][Full Text] [Related]
7. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
[TBL] [Abstract][Full Text] [Related]
8. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
[TBL] [Abstract][Full Text] [Related]
9. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
10. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
11. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
12. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
13. Psychotherapy in controlled psychopharmacology trials. Does it matter if we ignore it?
Koek RJ; Hejran RN; Mintz J
Contemp Clin Trials; 2005 Jun; 26(3):338-48. PubMed ID: 15911468
[TBL] [Abstract][Full Text] [Related]
14. Opioid antagonists for alcohol dependence.
Srisurapanont M; Jarusuraisin N
Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
[TBL] [Abstract][Full Text] [Related]
15. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
16. Methadone at tapered doses for the management of opioid withdrawal.
Amato L; Davoli M; Ferri M; Ali R
Cochrane Database Syst Rev; 2003; (3):CD003409. PubMed ID: 12917966
[TBL] [Abstract][Full Text] [Related]
17. Methadone at tapered doses for the management of opioid withdrawal.
Amato L; Davoli M; Ferri M; Ali R
Cochrane Database Syst Rev; 2002; (2):CD003409. PubMed ID: 12076479
[TBL] [Abstract][Full Text] [Related]
18. Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?
Emsley R; Fleischhacker WW
Schizophr Res; 2013 Nov; 150(2-3):427-33. PubMed ID: 24094881
[TBL] [Abstract][Full Text] [Related]
19. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
[TBL] [Abstract][Full Text] [Related]
20. Baclofen for alcohol withdrawal.
Liu J; Wang LN
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31689723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
